Investigative sites are the centerpiece of a successful clinical trial, but more often than not, sites are treated like a third spoke in a wheel. At Catalyst, we place a high value on the partnerships our sites and other study collaborators bring to ensure a successful clinical trial, resulting in new terapies for those battling cancer.
We’ve learned from you that many of the processes currently in practice place a high burden on sites, particularly during the start-up phase. As a result, we’ve rethought our process to eliminate and reduce redundancies to help drive efficiencies, reduce time and paperwork.
Experience You Can Rely On
We’ve also heard the frustration CRA turnover can create at the site level. To mitigate this, our goal is to align the Catalyst CRA and CSS staff with your site to obtain consistency, reliability and continuity. As our CRA staff averages an impressive 87% study retention rate, you can rest assured team turnover will have little impact on your trial experience with us. Additionally, our CRAs average 12 years of monitoring experience, including deep oncology expertise, which means you won’t ever see either a green or a non-oncology CRA show up at your doorstep.
Are You Ready To Join Us?
If you are an investigative site seeking more participation in clinical trials and working with a CRO who values sites as partners, contact us today. We look forward to hearing from you.